Benefits of Glucagon-Like Peptide-1 Agonists Use in Patients With Inflammatory Bowel Disease

被引：0
|
作者：
Abboud, Alan [1 ]
Aksan, Feyzullah [2 ]
Monzur, Farah [3 ]
机构：
[1] Stony Brook Univ Hosp, Ramsey, NJ USA
[2] SUNY Stony Brook, Renaissance Sch Med, Port Jefferson Stn, NY USA
[3] SUNY Stony Brook, Renaissance Sch Med, Stony Brook, NY USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2024年 / 119卷 / 10S期
关键词：
D O I：
10.14309/01.ajg.0001034412.42810.c5
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S1261
引用
收藏
页码：S899 / S899
页数：1
相关论文
共 50 条
  • [1] Tolerability and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists in Patients with Inflammatory Bowel Disease
    Clarke, Lindsay
    Passam, Ravi Teja
    Falahee, Bryn
    Jirapinyo, Pichamol
    Allegretti, Jessica R.
    Kelly, Colleen R.
    DIGESTIVE DISEASES AND SCIENCES, 2025,
  • [2] Weight Loss and Safety of Glucagon-like Peptide-1 Agonists in Inflammatory Bowel Disease Patients
    Anderson, Scott R.
    Coats, Sarah
    Ayoub, Malek
    McHenry, Scott
    Deepak, Parakkal
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S770 - S770
  • [3] GLUCAGON-LIKE PEPTIDE-1 RECEPTOR AGONISTS ARE ASSOCIATED WITH IMPROVED OUTCOMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
    Saadeh, Michael
    Chandar, Apoorva K.
    Baskin, Revital Gorodeski
    Mansoor, Emad
    Katz, Jeffry
    Cominelli, Fabio
    Nguyen, Vu Q.
    GASTROENTEROLOGY, 2024, 166 (05) : S1454 - S1454
  • [4] Glucagon-like peptide-1 agonists
    Padwal, Raj
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [5] Glucagon-Like Peptide-1 Agonists
    Stanton, Eloise W.
    Manasyan, Artur
    Banerjee, Rakhi
    Hong, Kurt
    Koesters, Emma
    Daar, David A.
    ANNALS OF PLASTIC SURGERY, 2025, 94 (01) : 121 - 127
  • [6] Use of glucagon-like peptide-1 receptor agonists for type 2 diabetes mellitus and outcomes of inflammatory bowel disease
    Desai, Aakash
    Petrov, Jessica
    Hashash, Jana G.
    Patel, Harsh
    Brahmbhatt, Bhaumik
    Kochhar, Gursimran S.
    Farraye, Francis A.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (05) : 620 - 632
  • [7] Glucagon-Like Peptide-1 Receptor Agonists
    Edelman, Steven V.
    JOURNAL OF FAMILY PRACTICE, 2017, 66 (10): : S12 - S16
  • [8] Safety and Effectiveness of Glucagon-Like Peptide 1 Receptor Agonists for Obesity in Patients With Inflammatory Bowel Disease
    Clarke, Lindsay
    Pasam, Ravi Teja
    Jirapinyo, Pichamol
    Allegretti, Jessica R.
    Kelly, Colleen R.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1000 - S1001
  • [9] The potential benefits of glucagon-like peptide-1 receptor agonists for diabetic retinopathy
    Pang, Baoying
    Zhou, Huanran
    Kuang, Hongyu
    PEPTIDES, 2018, 100 : 123 - 126
  • [10] Potential Benefits of Thiazolidinediones in Combination With Glucagon-Like Peptide-1 Receptor Agonists
    Florez, Hermes
    Correa, Ricardo
    Valencia, Willy Marcos
    JAMA NETWORK OPEN, 2025, 8 (03)
12345